Alnylam Pharmaceuticals is seeking an imaginative physician drug developer to provide clinical leadership in developing RNAi therapeutics across its rapidly expanding portfolio, covering rare genetic diseases, cardio‑metabolic diseases, neuroscience, hematology and hepatology. The successful candidate’s primary responsibility
Senior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address
Alnylam Pharmaceuticals is seeking an imaginative physician drug developer to provide clinical leadership in developing RNAi therapeutics across its rapidly expanding portfolio, covering rare genetic diseases, cardio‑metabolic diseases, neuroscience, hematology and hepatology. The successful candidate’s primary responsibility